Natera Share Holder Equity 2014-2025 | NTRA
Natera share holder equity from 2014 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- Natera share holder equity for the quarter ending September 30, 2025 was $1.252B, a 42.53% increase year-over-year.
- Natera share holder equity for 2024 was $1.195B, a 56.2% increase from 2023.
- Natera share holder equity for 2023 was $0.765B, a 8.44% increase from 2022.
- Natera share holder equity for 2022 was $0.706B, a 8.03% increase from 2021.
|
Natera Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $1,195 |
| 2023 | $765 |
| 2022 | $706 |
| 2021 | $653 |
| 2020 | $486 |
| 2019 | $279 |
| 2018 | $32 |
| 2017 | $25 |
| 2016 | $106 |
| 2015 | $185 |
| 2014 | $69 |
| 2013 | $14 |
|
Natera Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-09-30 | $1,252 |
| 2025-06-30 | $1,246 |
| 2025-03-31 | $1,240 |
| 2024-12-31 | $1,195 |
| 2024-09-30 | $879 |
| 2024-06-30 | $837 |
| 2024-03-31 | $794 |
| 2023-12-31 | $765 |
| 2023-09-30 | $785 |
| 2023-06-30 | $596 |
| 2023-03-31 | $651 |
| 2022-12-31 | $706 |
| 2022-09-30 | $362 |
| 2022-06-30 | $445 |
| 2022-03-31 | $542 |
| 2021-12-31 | $653 |
| 2021-09-30 | $759 |
| 2021-06-30 | $299 |
| 2021-03-31 | $372 |
| 2020-12-31 | $486 |
| 2020-09-30 | $536 |
| 2020-06-30 | $304 |
| 2020-03-31 | $259 |
| 2019-12-31 | $279 |
| 2019-09-30 | $85 |
| 2019-06-30 | $93 |
| 2019-03-31 | $5 |
| 2018-12-31 | $32 |
| 2018-09-30 | $57 |
| 2018-06-30 | $-22 |
| 2018-03-31 | $-4 |
| 2017-12-31 | $25 |
| 2017-09-30 | $30 |
| 2017-06-30 | $51 |
| 2017-03-31 | $74 |
| 2016-12-31 | $106 |
| 2016-09-30 | $140 |
| 2016-06-30 | $164 |
| 2016-03-31 | $182 |
| 2015-12-31 | $185 |
| 2015-09-30 | $206 |
| 2015-06-30 | $43 |
| 2015-03-31 | $0 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2013-12-31 | $14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $31.987B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.692B | 30.61 |
| HCA Healthcare (HCA) | United States | $107.089B | 17.73 |
| CVS Health (CVS) | United States | $99.777B | 11.47 |
| Elevance Health (ELV) | United States | $83.311B | 12.22 |
| Cencora (COR) | United States | $68.838B | 22.19 |
| DiDi Global (DIDIY) | China | $23.485B | 21.70 |
| Labcorp Holdings (LH) | United States | $22.455B | 17.12 |
| Medpace Holdings (MEDP) | United States | $17.208B | 42.72 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.445B | 0.00 |
| Viatris (VTRS) | United States | $14.812B | 5.52 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| ICON (ICLR) | Ireland | $14.747B | 14.63 |
| Solventum (SOLV) | United States | $13.786B | 13.38 |
| Revvity (RVTY) | United States | $12.755B | 23.49 |
| CochLear (CHEOY) | Australia | $11.760B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.813B | 20.82 |
| Avantor (AVTR) | United States | $8.291B | 12.67 |
| Sonic Healthcare (SKHHY) | Australia | $7.752B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.556B | 0.00 |
| HealthEquity (HQY) | United States | $7.294B | 27.27 |
| BrightSpring Health Services (BTSG) | United States | $7.070B | 42.15 |
| Bausch + Lomb (BLCO) | Canada | $6.078B | 39.91 |
| PACS (PACS) | United States | $6.072B | 36.92 |
| Sotera Health (SHC) | United States | $5.449B | 26.27 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.124B | 54.86 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.277B | 2.40 |
| Progyny (PGNY) | United States | $2.114B | 41.56 |
| Surgery Partners (SGRY) | United States | $2.057B | 26.50 |
| Establishment Labs Holdings (ESTA) | United States | $1.962B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.877B | 11.21 |
| Ardent Health (ARDT) | United States | $1.231B | 4.02 |
| Teladoc Health (TDOC) | United States | $1.115B | 0.00 |
| Nutex Health (NUTX) | United States | $1.080B | 8.26 |
| CareDx (CDNA) | United States | $1.029B | 16.82 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.734B | 4.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.706B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| CryoPort (CYRX) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 23.91 |
| Strata Critical Medical (SRTA) | United States | $0.515B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.445B | 8.19 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.288B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.279B | 58.75 |
| So-Young (SY) | China | $0.269B | 0.00 |
| KindlyMD (NAKA) | United States | $0.201B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.181B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.21 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |